These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

855 related articles for article (PubMed ID: 11559564)

  • 1. Specific inhibition of serine- and arginine-rich splicing factors phosphorylation, spliceosome assembly, and splicing by the antitumor drug NB-506.
    Pilch B; Allemand E; Facompré M; Bailly C; Riou JF; Soret J; Tazi J
    Cancer Res; 2001 Sep; 61(18):6876-84. PubMed ID: 11559564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Both phosphorylation and dephosphorylation of ASF/SF2 are required for pre-mRNA splicing in vitro.
    Cao W; Jamison SF; Garcia-Blanco MA
    RNA; 1997 Dec; 3(12):1456-67. PubMed ID: 9404896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered serine/arginine-rich protein phosphorylation and exonic enhancer-dependent splicing in Mammalian cells lacking topoisomerase I.
    Soret J; Gabut M; Dupon C; Kohlhagen G; Stévenin J; Pommier Y; Tazi J
    Cancer Res; 2003 Dec; 63(23):8203-11. PubMed ID: 14678976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poisoning of topoisomerase I by an antitumor indolocarbazole drug: stabilization of topoisomerase I-DNA covalent complexes and specific inhibition of the protein kinase activity.
    Labourier E; Riou JF; Prudhomme M; Carrasco C; Bailly C; Tazi J
    Cancer Res; 1999 Jan; 59(1):52-5. PubMed ID: 9892183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The [U4/U6.U5] tri-snRNP-specific 27K protein is a novel SR protein that can be phosphorylated by the snRNP-associated protein kinase.
    Fetzer S; Lauber J; Will CL; Lührmann R
    RNA; 1997 Apr; 3(4):344-55. PubMed ID: 9085842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. cdc2 kinase-mediated phosphorylation of splicing factor SF2/ASF.
    Okamoto Y; Onogi H; Honda R; Yasuda H; Wakabayashi T; Nimura Y; Hagiwara M
    Biochem Biophys Res Commun; 1998 Aug; 249(3):872-8. PubMed ID: 9731229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific commitment of different pre-mRNAs to splicing by single SR proteins.
    Fu XD
    Nature; 1993 Sep; 365(6441):82-5. PubMed ID: 8361546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylation status of the Kep1 protein alters its affinity for its protein binding partner alternative splicing factor ASF/SF2.
    Robard C; Daviau A; Di Fruscio M
    Biochem J; 2006 Nov; 400(1):91-7. PubMed ID: 16834570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new mechanism of acquisition of drug resistance by partial duplication of topoisomerase I.
    Komatani H; Morita M; Sakaizumi N; Fukasawa K; Yoshida E; Okura A; Yoshinari T; Nishimura S
    Cancer Res; 1999 Jun; 59(11):2701-8. PubMed ID: 10363995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The SR splicing factors ASF/SF2 and SC35 have antagonistic effects on intronic enhancer-dependent splicing of the beta-tropomyosin alternative exon 6A.
    Gallego ME; Gattoni R; Stévenin J; Marie J; Expert-Bezançon A
    EMBO J; 1997 Apr; 16(7):1772-84. PubMed ID: 9130721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SR proteins escort the U4/U6.U5 tri-snRNP to the spliceosome.
    Roscigno RF; Garcia-Blanco MA
    RNA; 1995 Sep; 1(7):692-706. PubMed ID: 7585254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cdc2-like kinases and DNA topoisomerase I regulate alternative splicing of tissue factor in human endothelial cells.
    Eisenreich A; Bogdanov VY; Zakrzewicz A; Pries A; Antoniak S; Poller W; Schultheiss HP; Rauch U
    Circ Res; 2009 Mar; 104(5):589-99. PubMed ID: 19168442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The second RNA-binding domain of the human splicing factor ASF/SF2 is the critical domain controlling adenovirus E1A alternative 5'-splice site selection.
    Dauksaite V; Akusjärvi G
    Biochem J; 2004 Jul; 381(Pt 2):343-50. PubMed ID: 15068396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific phosphorylation of SR proteins by mammalian DNA topoisomerase I.
    Rossi F; Labourier E; Forné T; Divita G; Derancourt J; Riou JF; Antoine E; Cathala G; Brunel C; Tazi J
    Nature; 1996 May; 381(6577):80-2. PubMed ID: 8609994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Clk/Sty protein kinase phosphorylates SR splicing factors and regulates their intranuclear distribution.
    Colwill K; Pawson T; Andrews B; Prasad J; Manley JL; Bell JC; Duncan PI
    EMBO J; 1996 Jan; 15(2):265-75. PubMed ID: 8617202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Over-expression of SR-cyclophilin, an interaction partner of nuclear pinin, releases SR family splicing factors from nuclear speckles.
    Lin CL; Leu S; Lu MC; Ouyang P
    Biochem Biophys Res Commun; 2004 Aug; 321(3):638-47. PubMed ID: 15358154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Titration of serine/arginine (SR) splicing factors during adenoviral infection modulates E1A pre-mRNA alternative splicing.
    Himmelspach M; Cavaloc Y; Chebli K; Stévenin J; Gattoni R
    RNA; 1995 Oct; 1(8):794-806. PubMed ID: 7493325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Phosphorylation of serine-arginine rich proteins--pleiotropic effect of one type posttranslational modification].
    Piekiełko-Witkowska A
    Postepy Biochem; 2006; 52(4):383-9. PubMed ID: 17536507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulated tissue-specific expression of antagonistic pre-mRNA splicing factors.
    Hanamura A; Cáceres JF; Mayeda A; Franza BR; Krainer AR
    RNA; 1998 Apr; 4(4):430-44. PubMed ID: 9630249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ASF/SF2-like maize pre-mRNA splicing factors affect splice site utilization and their transcripts are alternatively spliced.
    Gao H; Gordon-Kamm WJ; Lyznik LA
    Gene; 2004 Sep; 339():25-37. PubMed ID: 15363843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.